Table 1.
Clinical characteristics of the study population, n = 20.
Variable (n = 20, unless otherwise noted) | |
---|---|
Age at RAM cannula NIV initiation (months), median (IQR) | 5.8 (2.4-9.9) |
Gender, n (%) | |
Male | 6 (30) |
Female | 14 (70) |
Diagnoses, n (%) a | |
Bronchopulmonary dysplasia | 4 (20) |
Restrictive lung disease | 5 (25) |
Genetic disorders | 13 (65) |
Indications for NIV use, n (%) b | |
Sleep-related hypoventilation | 3 (15) |
Restrictive lung disease | 5 (25) |
Obstructive sleep apnea | 9 (45) |
Chronic respiratory failure with hypercapnia | 10 (50) |
Polysomnography results, n = 13 | |
Central sleep apnea, n (%) | 1 (7.7) |
Obstructive sleep apnea, n (%) | 12 (92.3) |
Sleep-related hypoxemia, n (%) | 6 (46.2) |
Sleep-related hypoventilation, n (%) | 7 (53.8) |
Total AHI (events per hour), median (IQR) | 16.5 (7.3-24.6) |
Obstructive AHI (events per hour), median (IQR) | 10.2 (5.5-23.0) |
Central AHI (events per hour), median (IQR) | 1.35 (0.5-3.5) |
Abbreviations: AHI, apnea-hypopnea index; IQR, interquartile range; NIV, noninvasive ventilation.
Genetic disorders included Trisomy 18 (n = 6), Trisomy 21 (n = 2), Prader-Willi syndrome (n = 1), partial trisomy 2q (n = 1), Crouzon syndrome (n = 1), and osteogenesis imperfecta (n = 2). Restrictive lung diseases included prune belly syndrome (n = 1), osteogenesis imperfecta (n = 2), arthrogryposis (n = 1), and thoracic insufficiency (n = 1). Two patients had Trisomy 21 and bronchopulmonary dysplasia. Two patients had osteogenesis imperfecta and restrictive lung disease.
Six patients had more than 1 indication for NIV use.